Manidipine Sandoz

Manidipine, the active ingredient in Manidipine Sandoz, is a calcium channel blocker presented as an oral tablet for systemic use. It treats hypertension in adult patients.

GNH USA supplies Manidipine Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manidipine is indicated for the management of elevated arterial blood pressure, a key component of cardiovascular disease control.

- Hypertension: lowers systolic and diastolic blood pressure, helping to reduce the risk of stroke and heart attack.

Manidipine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness. - Peripheral edema: swelling of ankles or feet. - Dizziness: especially when standing quickly. - Nausea: occasional upset stomach. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Bradycardia: abnormally slow heart rate. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, itching, or swelling. - Angioedema: swelling of face, lips, or throat. - Myocardial infarction: rare but reported in susceptible individuals.

Before initiating therapy, clinicians should evaluate patient history and concomitant conditions. - Renal impairment: adjust monitoring as clearance may be reduced. - Hepatic disease: consider liver function tests before use. - Concomitant antihypertensives: monitor for additive blood pressure lowering. - Elderly patients: start at lower dose and observe tolerance. - Pregnancy and lactation: avoid unless benefits outweigh risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Manidipine can interact with several drug classes, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels. - Grapefruit juice: can elevate drug concentration. - Other calcium channel blockers: risk of excessive hypotension.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive effect, watch for electrolyte imbalance. - Beta‑blockers: additive blood pressure reduction. - NSAIDs: may blunt antihypertensive response.